Global Human Prothrombin Complex Sales Market Report 2023

Publication ID:

PB501232198

Publication Date:

January 2, 2023

Pages:

123

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Market Analysis and Insights: Global Human Prothrombin Complex Market
Due to the COVID-19 pandemic, the global Human Prothrombin Complex market size is estimated to be worth US$ 1577 million in 2022 and is forecast to a readjusted size of US$ 3473.8 million by 2029 with a CAGR of 11.8% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, 500 IU/Vial accounting for % of the Human Prothrombin Complex global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hemophilia B segment is altered to an % CAGR throughout this forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Global Human Prothrombin Complex Scope and Market Size
The global Human Prothrombin Complex market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Human Prothrombin Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Human Prothrombin Complex Market Overview
1.1 Human Prothrombin Complex Product Scope
1.2 Human Prothrombin Complex Segment by Type
1.2.1 Global Human Prothrombin Complex Sales by Type (2018 & 2022 & 2029)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Segment by Application
1.3.1 Global Human Prothrombin Complex Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Human Prothrombin Complex Market Estimates and Forecasts (2018-2029)
1.4.1 Global Human Prothrombin Complex Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Human Prothrombin Complex Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Human Prothrombin Complex Price Trends (2018-2029)
2 Human Prothrombin Complex Estimates and Forecasts by Region
2.1 Global Human Prothrombin Complex Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Human Prothrombin Complex Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Human Prothrombin Complex Sales Market Share by Region (2018-2023)
2.2.2 Global Human Prothrombin Complex Revenue Market Share by Region (2018-2023)
2.3 Global Human Prothrombin Complex Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Human Prothrombin Complex Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Human Prothrombin Complex Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Prothrombin Complex Estimates and Projections (2018-2029)
2.4.2 Europe Human Prothrombin Complex Estimates and Projections (2018-2029)
2.4.3 China Human Prothrombin Complex Estimates and Projections (2018-2029)
2.4.4 Japan Human Prothrombin Complex Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Human Prothrombin Complex Estimates and Projections (2018-2029)
2.4.6 India Human Prothrombin Complex Estimates and Projections (2018-2029)
3 Global Human Prothrombin Complex Competition Landscape by Players
3.1 Global Top Human Prothrombin Complex Players by Sales (2018-2023)
3.2 Global Top Human Prothrombin Complex Players by Revenue (2018-2023)
3.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2022)
3.4 Global Human Prothrombin Complex Average Price by Company (2018-2023)
3.5 Manufacturers Human Prothrombin Complex Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Prothrombin Complex Market Size by Type
4.1 Global Human Prothrombin Complex Historic Market Review by Type (2018-2023)
4.1.1 Global Human Prothrombin Complex Sales by Type (2018-2023)
4.1.2 Global Human Prothrombin Complex Revenue by Type (2018-2023)
4.1.3 Global Human Prothrombin Complex Price by Type (2018-2023)
4.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Human Prothrombin Complex Sales Forecast by Type (2024-2029)
4.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2024-2029)
4.2.3 Global Human Prothrombin Complex Price Forecast by Type (2024-2029)
5 Global Human Prothrombin Complex Market Size by Application
5.1 Global Human Prothrombin Complex Historic Market Review by Application (2018-2023)
5.1.1 Global Human Prothrombin Complex Sales by Application (2018-2023)
5.1.2 Global Human Prothrombin Complex Revenue by Application (2018-2023)
5.1.3 Global Human Prothrombin Complex Price by Application (2018-2023)
5.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Human Prothrombin Complex Sales Forecast by Application (2024-2029)
5.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2024-2029)
5.2.3 Global Human Prothrombin Complex Price Forecast by Application (2024-2029)
6 United States Human Prothrombin Complex Market Facts & Figures
6.1 United States Human Prothrombin Complex Sales by Company
6.1.1 United States Human Prothrombin Complex Sales by Company (2018-2023)
6.1.2 United States Human Prothrombin Complex Revenue by Company (2018-2023)
6.2 United States Human Prothrombin Complex Sales Breakdown by Type
6.2.1 United States Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
6.2.2 United States Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
6.3 United States Human Prothrombin Complex Sales Breakdown by Application
6.3.1 United States Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
6.3.2 United States Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
7 Europe Human Prothrombin Complex Market Facts & Figures
7.1 Europe Human Prothrombin Complex Sales by Company
7.1.1 Europe Human Prothrombin Complex Sales by Company (2018-2023)
7.1.2 Europe Human Prothrombin Complex Revenue by Company (2018-2023)
7.2 Europe Human Prothrombin Complex Sales Breakdown by Type
7.2.1 Europe Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
7.2.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
7.3 Europe Human Prothrombin Complex Sales Breakdown by Application
7.3.1 Europe Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
7.3.2 Europe Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
8 China Human Prothrombin Complex Market Facts & Figures
8.1 China Human Prothrombin Complex Sales by Company
8.1.1 China Human Prothrombin Complex Sales by Company (2018-2023)
8.1.2 China Human Prothrombin Complex Revenue by Company (2018-2023)
8.2 China Human Prothrombin Complex Sales Breakdown by Type
8.2.1 China Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
8.2.2 China Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
8.3 China Human Prothrombin Complex Sales Breakdown by Application
8.3.1 China Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
8.3.2 China Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
9 Japan Human Prothrombin Complex Market Facts & Figures
9.1 Japan Human Prothrombin Complex Sales by Company
9.1.1 Japan Human Prothrombin Complex Sales by Company (2018-2023)
9.1.2 Japan Human Prothrombin Complex Revenue by Company (2018-2023)
9.2 Japan Human Prothrombin Complex Sales Breakdown by Type
9.2.1 Japan Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
9.2.2 Japan Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
9.3 Japan Human Prothrombin Complex Sales Breakdown by Application
9.3.1 Japan Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
9.3.2 Japan Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
10 Southeast Asia Human Prothrombin Complex Market Facts & Figures
10.1 Southeast Asia Human Prothrombin Complex Sales by Company
10.1.1 Southeast Asia Human Prothrombin Complex Sales by Company (2018-2023)
10.1.2 Southeast Asia Human Prothrombin Complex Revenue by Company (2018-2023)
10.2 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type
10.2.1 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Human Prothrombin Complex Sales Breakdown by Application
10.3.1 Southeast Asia Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
11 India Human Prothrombin Complex Market Facts & Figures
11.1 India Human Prothrombin Complex Sales by Company
11.1.1 India Human Prothrombin Complex Sales by Company (2018-2023)
11.1.2 India Human Prothrombin Complex Revenue by Company (2018-2023)
11.2 India Human Prothrombin Complex Sales Breakdown by Type
11.2.1 India Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
11.2.2 India Human Prothrombin Complex Sales Breakdown by Type (2024-2029)
11.3 India Human Prothrombin Complex Sales Breakdown by Application
11.3.1 India Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
11.3.2 India Human Prothrombin Complex Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Human Prothrombin Complex Business
12.1 Takeda
12.1.1 Takeda Corporation Information
12.1.2 Takeda Business Overview
12.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Takeda Human Prothrombin Complex Products Offered
12.1.5 Takeda Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.2.4 CSL Human Prothrombin Complex Products Offered
12.2.5 CSL Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Business Overview
12.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Grifols Human Prothrombin Complex Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Octapharma Human Prothrombin Complex Products Offered
12.4.5 Octapharma Recent Development
12.5 Hualan Biological
12.5.1 Hualan Biological Corporation Information
12.5.2 Hualan Biological Business Overview
12.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Hualan Biological Human Prothrombin Complex Products Offered
12.5.5 Hualan Biological Recent Development
12.6 Meheco Xinxing Pharma
12.6.1 Meheco Xinxing Pharma Corporation Information
12.6.2 Meheco Xinxing Pharma Business Overview
12.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
12.6.5 Meheco Xinxing Pharma Recent Development
13 Human Prothrombin Complex Manufacturing Cost Analysis
13.1 Human Prothrombin Complex Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Prothrombin Complex
13.4 Human Prothrombin Complex Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Prothrombin Complex Distributors List
14.3 Human Prothrombin Complex Customers
15 Market Dynamics
15.1 Human Prothrombin Complex Industry Trends
15.2 Human Prothrombin Complex Market Drivers
15.3 Human Prothrombin Complex Market Challenges
15.4 Human Prothrombin Complex Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂